Effective with date of service Dec. 17, 2021, Medicaid and NC Health Choice cover efgartigimod alfa-fcab injection, for intravenous use (VYVGART™).
Effective with date of service Dec. 30, 2021, Medicaid and NC Health Choice cover ropeginterferon alfa-2b-njft injection, for subcutaneous use (BESREMI®).
Revisions to previous scope of authorization
Effective with date of service Dec. 1, 2021, Medicaid and NC Health Choice cover ranibizumab injection for intravitreal use via ocular implant.
Certain immunocompromised children will qualify for third dose of Pfizer-BioN Tech Vaccine
Oral tablets covered for those in a home setting
FDA has expanded the use of single booster dose to include ages 12-15.
Emergency use of Evusheld approved by FDA
Effective with date of service Nov 1, 2021, Medicaid and NC Health Choice programs cover pneumococcal 15-valent conjugate vaccine suspension for intramuscular injection (Vaxneuvance™).
Effective with date of service Oct. 22, 2021, Medicaid and NC Health Choice programs cover afamelanotide implant, for subcutaneous use (Scenesse®).